clinical trial · NCT05523596
A Phase 1 Study of the Safety and Tolerability of ICM20 in Adults
IC-MedTech Corporation·phase1·completed·n = 13
Safety IssuesICM20Benznidazole
brief summary
A Phase 1 Non-Randomized Open Label Study of Oral ICM20
started
Aug 20, 2023
primary completion
Oct 3, 2025
completion
Oct 3, 2025
last updated
Apr 16, 2026
detailed description
This is a Phase 1 open label study to access the safety and tolerability of ICM20 alone and in combination with benznidazole
official title
A Phase 1 Non-Randomized Open Label Study of ICM20
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol